MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
24.49
+1.33 (5.74%)
Sep 26, 2024, 4:00 PM EDT - Market closed
MBX Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 |
| Sep '24 Sep 26, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 818 | - | - |
| Enterprise Value | 915 | - | - |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.01 |
| Debt / FCF Ratio | -0.01 | -0.01 | -0.02 |
| Quick Ratio | 6.76 | 20.60 | 12.42 |
| Current Ratio | 7.17 | 21.26 | 12.89 |
| Return on Equity (ROE) | - | -53.75% | - |
| Return on Assets (ROA) | - | -34.14% | - |
| Return on Capital (ROIC) | - | -36.19% | - |
| Buyback Yield / Dilution | -52.73% | - |
| Total Shareholder Return | -52.73% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.